These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27503482)

  • 1. Ingenol Disoxate: A Novel 4-Isoxazolecarboxylate Ester of Ingenol with Improved Properties for Treatment of Actinic Keratosis and Other Non-Melanoma Skin Cancers.
    Bertelsen M; Stahlhut M; Grue-Sørensen G; Liang X; Christensen GB; Skak K; Engell KM; Högberg T
    Dermatol Ther (Heidelb); 2016 Dec; 6(4):599-626. PubMed ID: 27503482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dose-finding trial with a novel ingenol derivative (ingenol disoxate: LEO 43204) for field treatment of actinic keratosis on full face or 250 cm
    Bourcier M; Stein Gold L; Guenther L; Andreassen CM; Selmer J; Goldenberg G
    J Dermatolog Treat; 2017 Nov; 28(7):652-658. PubMed ID: 28264612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer.
    Erlendsson AM
    Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses, biological evaluation and SAR of ingenol mebutate analogues for treatment of actinic keratosis and non-melanoma skin cancer.
    Liang X; Grue-Sørensen G; Månsson K; Vedsø P; Soor A; Stahlhut M; Bertelsen M; Engell KM; Högberg T
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5624-9. PubMed ID: 23993332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: A Phase II Trial.
    Siegel DM; Tyring S; Nahm WK; Østerdal ML; Petersen AH; Berman B
    J Clin Aesthet Dermatol; 2017 Dec; 10(12):19-26. PubMed ID: 29399263
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
    Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
    J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A seamless phase I/II dose-finding trial assessing ingenol disoxate (LEO 43204) for field treatment of actinic keratosis on the scalp.
    Weiss J; Ulrich M; Bukhalo M; Østerdal ML; Bang B; Hanke CW
    Br J Dermatol; 2017 Jun; 176(6):1456-1464. PubMed ID: 28078678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel.
    Berman B
    Clin Cosmet Investig Dermatol; 2012; 5():111-22. PubMed ID: 22956883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differentially expressed genes in actinic keratosis samples treated with ingenol mebutate gel.
    Segura S; Gadea A; Nonell L; Andrades E; Sánchez S; Pujol R; Hernández-Muñoz I; Toll A
    PLoS One; 2020; 15(5):e0232146. PubMed ID: 32413042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and Safety of Ingenol Disoxate Gel Administered Under Maximum-Use Conditions to Patients With Actinic Keratosis.
    Lain E; Skov T; Hall A
    Clin Drug Investig; 2018 Mar; 38(3):249-257. PubMed ID: 29204958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
    N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study.
    Siller G; Gebauer K; Welburn P; Katsamas J; Ogbourne SM
    Australas J Dermatol; 2009 Feb; 50(1):16-22. PubMed ID: 19178487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis.
    Stockfleth E; Bastian M
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):911-918. PubMed ID: 30074409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive monitoring of subclinical and clinical actinic keratosis of face and scalp under topical treatment with ingenol mebutate gel 150 mcg/g by means of reflectance confocal microscopy and optical coherence tomography: New perspectives and comparison of diagnostic techniques.
    Ruini C; Hartmann D; Bastian M; Ruzicka T; French LE; Berking C; von Braunmühl T
    J Biophotonics; 2019 Jul; 12(7):e201800391. PubMed ID: 30653833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-Day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: Cosmetic Outcomes and Patient Satisfaction from a Phase II Trial.
    Berman B; Tyring S; Nahm WK; Østerdal ML; Petersen AH; Siegel DM
    J Clin Aesthet Dermatol; 2017 Nov; 10(11):26-32. PubMed ID: 29399258
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of apoptosis-associated molecules Erythroid differentiation regulator 1, bcl-2 and p53 in actinic keratosis after treatment with ingenol mebutate.
    Woo YR; Lim JH; Jeong SW; Cho DH; Park HJ
    Exp Dermatol; 2017 Nov; 26(11):1012-1017. PubMed ID: 28370377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ingenol mebutate treatment in actinic keratosis - clinical effectiveness and potential side effects.
    Lesiak A; Maćkowska A; Bednarski IA; Kolano P; Olejniczak-Staruch I; Woźniacka A; Sieniawska J; Narbutt J
    Postepy Dermatol Alergol; 2019 Aug; 36(4):468-471. PubMed ID: 31616223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prospective Pilot Clinical Trial to Evaluate the Efficacy and Safety of Topical Therapy with Ingenol Mebutate Gel 0.015% for Actinic Keratosis on an Expanded Area of the Chest.
    Wu DC; Guiha I; Goldman MP
    J Clin Aesthet Dermatol; 2017 Aug; 10(8):31-36. PubMed ID: 28979661
    [No Abstract]   [Full Text] [Related]  

  • 19. Ingol and Ingenol-Type Diterpenes from
    Hammadi R; Kúsz N; Dávid CZ; Behány Z; Papp L; Kemény L; Hohmann J; Lakatos L; Vasas A
    Plants (Basel); 2021 Jun; 10(6):. PubMed ID: 34198524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Histologic Evaluation of Ingenol Mebutate 0.015% Gel for the Cosmetic Improvement of Photoaged Skin.
    Handler MZ; Bloom BS; Goldberg DJ
    Dermatol Surg; 2018 Jan; 44(1):61-67. PubMed ID: 28858927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.